Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine

J Cardiovasc Pharmacol. 2016 Feb;67(2):191-2. doi: 10.1097/FJC.0000000000000324.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Hypercholesterolemia / drug therapy*
  • PCSK9 Inhibitors*
  • Proprotein Convertase 9 / metabolism
  • Proprotein Convertases / antagonists & inhibitors
  • Proprotein Convertases / metabolism
  • Translational Research, Biomedical / methods*
  • Translational Research, Biomedical / trends

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • PCSK9 Inhibitors
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • alirocumab